OTOTOXICITY side effect
What is OTOTOXICITY ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
OTOTOXICITY and Recently Reported Side Effects
OTOTOXICITY and 15 most Active Side Effect polls
OTOTOXICITY and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with OTOTOXICITY
ACETAMINOPHEN ATENOLOL AZITHROMYCIN BEVACIZUMAB CARBOPLATIN CYMBALTA EPIRUBICIN GEMZAR GENTAMICIN IFOSFAMIDE KEFLEX RITUXIMAB SUTENT VIRAFERONPEGGentamicin Side Effects Report #5621735-9
Consumer or non-health professional from UNITED KINGDOM reported GENTAMICIN problem on Jan 29, 2008. Female patient, 65 years of age, was diagnosed with staphylococcal sepsis and was treated with GENTAMICIN. After drug was administered, patient experienced the following problems/side effects: ototoxicity, . GENTAMICIN dosage: unknown. During the same period patient was treated with ALFACALCIDOL, CALCICHEW, FLUCLOXACILLIN, GLICLAZIDE, NIFEDIPINE, VANCOMYCIN, WARFARIN. Patient recovered.
Gentamicin Side Effects Report #5566116-1
GENTAMICIN problem was reported by a Pharmacist from UNITED STATES on Dec 17, 2007. Male patient, 70 years of age, weighting 167.3 lb, was diagnosed with endocarditis and was treated with GENTAMICIN. After drug was administered, patient experienced the following problems/side effects: ototoxicity, . GENTAMICIN dosage: 80 MG Q8H - 100 MG Q 12. During the same period patient was treated with DIGOXIN, LEVOTHYROXINE, AMPICILLIN, ATORVASTATIN, MILK OF MAG, HEPARIN, ENOXAPARIN, WARFARIN. Patient recovered.
Rituximab Side Effects Report #5490679-8
Physician from ISRAEL reported RITUXIMAB problem on Oct 10, 2007. Male patient was diagnosed with diffuse large b-cell lymphoma and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: ototoxicity, . RITUXIMAB dosage: 375 MG/M2, UNK. During the same period patient was treated with IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE, LENOGRASTIM. Patient was hospitalized. Patient recovered.
Ifosfamide Side Effects Report #5491806-9
IFOSFAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 10, 2007. Male patient, 64 years of age, was diagnosed with diffuse large b-cell lymphoma, prophylaxis and was treated with IFOSFAMIDE. After drug was administered, patient experienced the following problems/side effects: ototoxicity, pneumonia streptococcal, pulmonary cavitation, . IFOSFAMIDE dosage: unknown. During the same period patient was treated with MESNA, ETOPOSIDE, CARBOPLATIN, RITUXAN, LOSEC. Patient was hospitalized. Patient recovered.
Gentamicin Side Effects Report #5396908-3
Consumer or non-health professional from UNITED KINGDOM reported GENTAMICIN SULPHATE problem on July 11, 2007. Male patient, 69 years of age, weighting 110.2 lb, was diagnosed with pseudomonas infection and was treated with GENTAMICIN SULPHATE. After drug was administered, patient experienced the following problems/side effects: ototoxicity, . GENTAMICIN SULPHATE dosage: unknown. During the same period patient was treated with GENTAMICIN SULPHATE, ALENDRONATE, CARBOCISTEINE, CEFTAZIDIME, ENOXAPARIN, FOLIC ACID, LACTULOSE, OMEPRAZOLE. Patient recovered.
Gentamicin Side Effects Report #5396908-3
GENTAMICIN SULPHATE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 11, 2007. Male patient, 69 years of age, weighting 110.2 lb, was diagnosed with pseudomonas infection and was treated with GENTAMICIN SULPHATE. After drug was administered, patient experienced the following problems/side effects: ototoxicity, . GENTAMICIN SULPHATE dosage: unknown. During the same period patient was treated with GENTAMICIN SULPHATE, ALENDRONATE, CARBOCISTEINE, CEFTAZIDIME, ENOXAPARIN, FOLIC ACID, LACTULOSE, OMEPRAZOLE. Patient recovered.
Bevacizumab Side Effects Report #5764219-X
Physician from UNITED STATES reported BEVACIZUMAB problem on June 02, 2008. Male patient, 57 years of age, was diagnosed with nasopharyngeal cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: ototoxicity, pyrexia, . BEVACIZUMAB dosage: 15 MG/KG, UNK. During the same period patient was treated with FLUOROURACIL, CISPLATIN, ALLOPURINOL, LEXAPRO, KYTRIL, REGLAN, ATIVAN, RANITIDINE. Patient was hospitalized. Patient recovered.
Gentamicin Side Effects Report #5373333-2
GENTAMICIN problem was reported by a Consumer or non-health professional from UNITED STATES on June 26, 2007. Female patient, 43 years of age, weighting 175.0 lb, was diagnosed with pseudomonas infection, sinusitis and was treated with GENTAMICIN. After drug was administered, patient experienced the following problems/side effects: ototoxicity, vestibular disorder, . GENTAMICIN dosage: unknown. Patient recovered.
Atenolol Side Effects Report #5344203-0
Consumer or non-health professional from UNITED STATES reported ATENOLOL problem on May 31, 2007. Female patient, 48 years of age, weighting 225.0 lb, was diagnosed with heart rate irregular and was treated with ATENOLOL. After drug was administered, patient experienced the following problems/side effects: ototoxicity, tinnitus, vestibular disorder, . ATENOLOL dosage: unknown. Patient recovered.
Cymbalta Side Effects Report #5340533-7
CYMBALTA problem was reported by a Health Professional from UNITED STATES on Dec 12, 2006. Female patient was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: ototoxicity, . CYMBALTA dosage: 60MG. Patient recovered.
Ifosfamide Side Effects Report #5660851-2
Consumer or non-health professional from UNITED STATES reported IFOSFAMIDE problem on Mar 03, 2008. Male patient, 64 years of age, was diagnosed with diffuse large b-cell lymphoma, prophylaxis and was treated with IFOSFAMIDE. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, ototoxicity, pneumonia streptococcal, pulmonary cavitation, . IFOSFAMIDE dosage: unknown. During the same period patient was treated with MESNA, ETOPOSIDE, CARBOPLATIN, MABTHERA, LOSEC I, SIMVASTATIN, ASPIRIN. Patient was hospitalized. Patient died on 04/04/2005.
Gemzar Side Effects Report #5636365-2
GEMZAR problem was reported by a Physician from CZECH REPUBLIC on Feb 12, 2008. Male patient was diagnosed with germ cell cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: haematotoxicity, ototoxicity, . GEMZAR dosage: 1000 MG/M2, DAY 1 AND 5 OF 3-4 WEEK CYCLES. During the same period patient was treated with PACLITAXEL. Patient recovered.
Gentamicin Side Effects Report #5449072-6
Consumer or non-health professional from UNITED KINGDOM reported GENTAMICIN SULPHATE problem on Sept 03, 2007. Female patient, 55 years of age, weighting 220.5 lb, was diagnosed with endocarditis staphylococcal, systemic candida, toxic shock syndrome staphylococcal, fluid overload and was treated with GENTAMICIN SULPHATE. After drug was administered, patient experienced the following problems/side effects: deafness, ototoxicity, . GENTAMICIN SULPHATE dosage: unknown. During the same period patient was treated with AMBAZONE, CLINDAMYCIN, FLUCLOXACILLIN, FUROSEMIDE, RIFAMPICIN, XIGRIS. Patient recovered.
Viraferonpeg Side Effects Report #5451929-7
VIRAFERONPEG problem was reported by a Physician from FRANCE on Aug 31, 2007. Female patient, 67 years of age, weighting 132.3 lb, was diagnosed with hepatitis c and was treated with VIRAFERONPEG. After drug was administered, patient experienced the following problems/side effects: hypoacusis, ototoxicity, tinnitus, vertigo, . VIRAFERONPEG dosage: 1.5 MG/KG;QW;SC. During the same period patient was treated with REBETOL. Patient recovered.
Acetaminophen Side Effects Report #5422651-8
Consumer or non-health professional from UNITED STATES reported ACETAMINOPHEN AND HYDROCODONE BITARTRATE problem on Aug 14, 2007. Female patient, 28 years of age, was treated with ACETAMINOPHEN AND HYDROCODONE BITARTRATE. After drug was administered, patient experienced the following problems/side effects: deafness neurosensory, ototoxicity, tinnitus, . ACETAMINOPHEN AND HYDROCODONE BITARTRATE dosage: GREATER THAN 50 MG PER DAY. During the same period patient was treated with ACETAMINOPHEN AND HYDROCODONE BITARTRATE. Patient recovered.
Keflex Side Effects Report #5742214-4
KEFLEX problem was reported by a Physician from UNITED STATES on Aug 03, 2007. Female patient, 31 years of age, weighting 110.0 lb, was treated with KEFLEX. After drug was administered, patient experienced the following problems/side effects: middle ear disorder, ototoxicity, vestibular disorder, visual disturbance, . KEFLEX dosage: 500 MG, 4/D, ORAL. Patient recovered.
Viraferonpeg Side Effects Report #5724462-2
Physician from FRANCE reported VIRAFERONPEG problem on Apr 24, 2008. Female patient, 67 years of age, weighting 132.3 lb, was diagnosed with hepatitis c and was treated with VIRAFERONPEG. After drug was administered, patient experienced the following problems/side effects: deafness unilateral, ototoxicity, tinnitus, vertigo, . VIRAFERONPEG dosage: 1.5 MG/KG;QW;SC. During the same period patient was treated with REBETOL. Patient recovered.
Azithromycin Side Effects Report #5663785-2
AZITHROMYCIN problem was reported by a Pharmacist from UNITED STATES on Feb 26, 2008. Male patient, 35 years of age, weighting 143.3 lb, was diagnosed with mycobacterium avium complex infection, mycobacterium kansasii infection and was treated with AZITHROMYCIN. After drug was administered, patient experienced the following problems/side effects: deafness neurosensory, dizziness, ototoxicity, tinnitus, . AZITHROMYCIN dosage: 500 MG, QD. During the same period patient was treated with ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, RIFABUTIN, CIPROFLOXACIN, SULFAMETHOXAZOLE AND TRIMETHOPRIM, FLUCONAZOLE, ZIDOVUDINE. Patient was hospitalized. Patient recovered.
Azithromycin Side Effects Report #5668238-3
Pharmacist from UNITED STATES reported AZITHROMYCIN problem on Feb 26, 2008. Female patient, 47 years of age, was diagnosed with pneumonia and was treated with AZITHROMYCIN. After drug was administered, patient experienced the following problems/side effects: deafness transitory, neuropathy peripheral, ototoxicity, tinnitus, . AZITHROMYCIN dosage: 500 MG EVERY 24 HOURS, INTRAVENOUS. During the same period patient was treated with SULFAMETHOXAZOLE AND TRIMETHOPRIM, TICARCILLIN, GANCICLOVIR, TACROLIMUS, MYCOPHENOLATE, PREDNISONE, LANSOPRAZOLE, DILTIAZEM. Patient was hospitalized. Patient recovered.
Epirubicin Side Effects Report #5633443-9
EPIRUBICIN HYDROCHLORIDE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 11, 2008. Male patient was diagnosed with rhabdomyosarcoma and was treated with EPIRUBICIN HYDROCHLORIDE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, interstitial lung disease, ototoxicity, recall phenomenon, respiratory failure, . EPIRUBICIN HYDROCHLORIDE dosage: DAILY DOSE:150MG/M*2. During the same period patient was treated with CARBOPLATIN, VINCRISTINE SULPHATE, ETOPOSIDE, IFOSFAMIDE, DACTINOMYCIN. Patient was hospitalized. Patient died.
Gentamicin Side Effects Report #5586917-3
Pharmacist from UNITED STATES reported GENTAMICIN problem on Jan 08, 2008. Female patient, 47 years of age, was diagnosed with osteomyelitis, staphylococcal infection and was treated with GENTAMICIN. After drug was administered, patient experienced the following problems/side effects: ataxia, nausea, ototoxicity, tinnitus, vertigo, . GENTAMICIN dosage: unknown. During the same period patient was treated with VANCOMYCIN. Patient was hospitalized. Patient recovered.
Epirubicin Side Effects Report #5403231-7
EPIRUBICIN HYDROCHLORIDE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 20, 2007. Male patient was diagnosed with rhabdomyosarcoma and was treated with EPIRUBICIN HYDROCHLORIDE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, interstitial lung disease, ototoxicity, recall phenomenon, respiratory failure, . EPIRUBICIN HYDROCHLORIDE dosage: DAILY DOSE:150MG/M*2. During the same period patient was treated with CARBOPLATIN, VINCRISTINE SULPHATE, ETOPOSIDE, IFOSFAMIDE, DACTINOMYCIN. Patient was hospitalized. Patient died.
Carboplatin Side Effects Report #5385093-X
Physician from GERMANY reported CARBOPLATIN problem on June 26, 2007. Male patient, 19 years of age, was diagnosed with medulloblastoma and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: fall, hypersensitivity, ototoxicity, septic shock, . CARBOPLATIN dosage: 200 MG/M2 FREQ UNK IV. During the same period patient was treated with ETOPOSIDE. Patient was hospitalized. Patient recovered.
Carboplatin Side Effects Report #5385093-X
CARBOPLATIN problem was reported by a Physician from GERMANY on June 26, 2007. Male patient, 19 years of age, was diagnosed with medulloblastoma and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: fall, hypersensitivity, ototoxicity, septic shock, . CARBOPLATIN dosage: 200 MG/M2 FREQ UNK IV. During the same period patient was treated with ETOPOSIDE. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #5781019-5
Consumer or non-health professional from FRANCE reported SUTENT problem on June 09, 2008. Male patient, 73 years of age, was diagnosed with renal neoplasm and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: asthenia, diarrhoea, ototoxicity, thrombocytopenia, . SUTENT dosage: DAILY DOSE:50MG. Patient recovered.
Epirubicin Side Effects Report #5342511-0
EPIRUBICIN HYDROCHLORIDE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on May 21, 2007. Male patient was diagnosed with rhabdomyosarcoma and was treated with EPIRUBICIN HYDROCHLORIDE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, interstitial lung disease, ototoxicity, recall phenomenon, respiratory failure, . EPIRUBICIN HYDROCHLORIDE dosage: DAILY DOSE:150MG/M*2. During the same period patient was treated with CARBOPLATIN, VINCRISTINE SULPHATE, ETOPOSIDE, IFOSFAMIDE, DACTINOMYCIN. Patient died.
Epirubicin Side Effects Report #5362641-7
Consumer or non-health professional from UNITED KINGDOM reported EPIRUBICIN HYDROCHLORIDE problem on June 07, 2007. Male patient was diagnosed with rhabdomyosarcoma and was treated with EPIRUBICIN HYDROCHLORIDE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, interstitial lung disease, ototoxicity, recall phenomenon, respiratory failure, . EPIRUBICIN HYDROCHLORIDE dosage: DAILY DOSE:150MG/M*2. During the same period patient was treated with CARBOPLATIN, VINCRISTINE SULPHATE, ETOPOSIDE, IFOSFAMIDE, DACTINOMYCIN. Patient died.
Epirubicin Side Effects Report #5375325-6
EPIRUBICIN HYDROCHLORIDE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on June 18, 2007. Male patient was diagnosed with rhabdomyosarcoma and was treated with EPIRUBICIN HYDROCHLORIDE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, interstitial lung disease, ototoxicity, recall phenomenon, respiratory failure, . EPIRUBICIN HYDROCHLORIDE dosage: DAILY DOSE:150MG/M*2. During the same period patient was treated with CARBOPLATIN, VINCRISTINE SULPHATE, ETOPOSIDE, IFOSFAMIDE, DACTINOMYCIN. Patient was hospitalized. Patient died.